Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING pathway agonism as a cancer therapeutic
Blake Flood, Emily F. Higgs, Shuyin Li, et al.
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 24-38
Open Access | Times Cited: 265

Showing 26-50 of 265 citing articles:

Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Jason J. Luke, Sarina A. Piha‐Paul, Theresa Medina, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 13, pp. 2435-2444
Open Access | Times Cited: 62
Mn-based cGAS-STING activation for tumor therapy
Aiping Huang, Wenhu Zhou
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 1, pp. 19-43
Open Access | Times Cited: 46
Bioactivable STING Nanoagonists to Synergize NIR‐II Mild Photothermal Therapy Primed Robust and Long‐Term Anticancer Immunity
Wen Ma, Rui Sun, Longguang Tang, et al.
Advanced Materials (2023) Vol. 35, Iss. 48
Closed Access | Times Cited: 44
ATP‐Responsive Manganese‐Based Bacterial Materials Synergistically Activate the cGAS‐STING Pathway for Tumor Immunotherapy
Yang Huang, Sisi Yang, Quanshi Guo, et al.
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 26
cGAS–STING, an important signaling pathway in diseases and their therapy
Qijie Li, Ping Wu, Qiujing Du, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 21
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 19
Metal coordination‐driven assembly of stimulator of interferon genes‐activating nanoparticles for tumor chemo‐immunotherapy
Guiqiang Zhang, Ning Wang, Yuan Ma, et al.
BMEMat (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 16
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
Xu Liu, Cheng Yang, Yao Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
cGAS‐STING pathway agonists are promising vaccine adjuvants
Xinyu Tian, Jiayuan Ai, Xiaohe Tian, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1768-1799
Open Access | Times Cited: 15
Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors
Shiyun Xian, Xiaona Chen, Sihang Ren, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3044-3057
Closed Access | Times Cited: 15
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Jingjing Liang, Huifang Wang, Wenxiu Ding, et al.
Science Advances (2020) Vol. 6, Iss. 35
Open Access | Times Cited: 119
<p>Toll-Like Receptor 9 Agonists in Cancer</p>
Lilit Karapetyan, Jason J. Luke, Diwakar Davar
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 10039-10061
Open Access | Times Cited: 106
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Yun Liu, Jianfeng Guo, Leaf Huang
Theranostics (2020) Vol. 10, Iss. 7, pp. 3099-3117
Open Access | Times Cited: 101
Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response
Christopher Garris, Jason J. Luke
Clinical Cancer Research (2020) Vol. 26, Iss. 15, pp. 3901-3907
Open Access | Times Cited: 101
The continued advance of vaccine adjuvants – ‘we can work it out’
Derek T. O’Hagan, Rushit N. Lodaya, Giuseppe Lofano
Seminars in Immunology (2020) Vol. 50, pp. 101426-101426
Open Access | Times Cited: 101
Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation
Annamaria Gullà, Eugenio Morelli, Mehmet Samur, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 5, pp. 468-483
Open Access | Times Cited: 101
Immunogenic cell death in colon cancer prevention and therapy
Hang Ruan, Brian J. Leibowitz, Lin Zhang, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 7, pp. 783-793
Open Access | Times Cited: 92
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
Mohamed Wehbe, Lihong Wang-Bishop, Kyle W. Becker, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 1118-1129
Open Access | Times Cited: 92
Targeting Innate Immunity in Cancer Therapy
Srikrishnan Rameshbabu, Brian Labadie, Anna Argulian, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 138-138
Open Access | Times Cited: 89
The Age of Cyclic Dinucleotide Vaccine Adjuvants
Himanshu Gogoi, Samira Mansouri, Lei Jin
Vaccines (2020) Vol. 8, Iss. 3, pp. 453-453
Open Access | Times Cited: 78
STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation?
Judith A. Smith
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 77
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
Robert J. Walsh, Ross A. Soo
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 71
Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist
Shanshan Gou, Wenwen Liu, Shuai Wang, et al.
Nano Letters (2021) Vol. 21, Iss. 23, pp. 9939-9950
Closed Access | Times Cited: 70
The Evolution of STING Signaling and Its Involvement in Cancer
Nimi Vashi, Samuel F. Bakhoum
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 6, pp. 446-460
Open Access | Times Cited: 59

Scroll to top